These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 4632454)

  • 21. [Fetomaternal transfusion, rhesus immunization and prevention].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1974; 36(4):185-218. PubMed ID: 4216208
    [No Abstract]   [Full Text] [Related]  

  • 22. [Placenta and maternal and fetal iso-immunization].
    von Muralt G
    Geburtshilfe Frauenheilkd; 1972 Feb; 32(2):81-8. PubMed ID: 4622621
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fetomaternal transfusion in abortion and pregnancy interruptions and Rh-prevention].
    Radzuweit H; Krüger B
    Zentralbl Gynakol; 1975; 97(22):1367-74. PubMed ID: 812290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of abortion and pregnancy interruption for the passage of fetal erythrocytes and anti Rh (D) antibody formation].
    Krikal Z; Gazárek F; Smýkalová M; Konecná L
    Cesk Gynekol; 1970 Jul; 35(6):359-60. PubMed ID: 4988522
    [No Abstract]   [Full Text] [Related]  

  • 25. Effectiveness of Rh prophylaxis.
    Woodrow JC
    Haematologia (Budap); 1974; 8(1-4):281-90. PubMed ID: 4218822
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fetal hemoglobin and fetal erythrocytes in maternal blood during pregnancy and delivery].
    Betke K; Nierhaus K
    Munch Med Wochenschr; 1968 Mar; 110(9):509-16. PubMed ID: 4970279
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of Rh haemolytic disease.
    Clarke CA
    Nurs Mirror Midwives J; 1974 Oct; 139(17):57-9. PubMed ID: 4139694
    [No Abstract]   [Full Text] [Related]  

  • 28. The pathogenesis and prevention of Rh immunization.
    Zipursky A; Israels LG
    Can Med Assoc J; 1967 Nov; 97(21):1245-57. PubMed ID: 4168032
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of Rh sensitization from fetomaternal microtransfusions.
    Schneider J; Preisler O
    Obstet Gynecol; 1966 Nov; 28(5):615-21. PubMed ID: 4958982
    [No Abstract]   [Full Text] [Related]  

  • 30. [Obstetrical management in the prevention of Rh factor immunization].
    Medina Aguilar R
    Ginecol Obstet Mex; 1969 Mar; 25(149):257-66. PubMed ID: 4181035
    [No Abstract]   [Full Text] [Related]  

  • 31. [Problems of immunology and pregnancy].
    Viazov OE; Verbitiskiĭ MSh
    Vopr Okhr Materin Det; 1973 Jul; 18(7):57-62. PubMed ID: 4148635
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fetomaternal immunization of pregnant women to HL-A alloantigens and ABO and Rh antigens. II. Clinical observations on the course of pregnancy].
    Zdebski Z
    Folia Med Cracov; 1974; 16(3):341-53. PubMed ID: 4212657
    [No Abstract]   [Full Text] [Related]  

  • 33. [Composition of intervillous thrombi from maternal and fetal blood].
    Gille J; Schwerd W; von Criegern T
    Z Geburtshilfe Perinatol; 1986; 190(3):133-6. PubMed ID: 2429464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrapartum fetomaternal bleeding in Rh-negative women.
    Lloyd LK; Miya F; Hebertson RM; Kochenour NK; Scott JR
    Obstet Gynecol; 1980 Sep; 56(3):285-8. PubMed ID: 6775254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Demonstration and elimination of HbF cells in mothers after the birth of ABO-incompatible children].
    Luboldt W
    Bibl Haematol; 1969; 32():312-8. PubMed ID: 4981567
    [No Abstract]   [Full Text] [Related]  

  • 36. [Practical realization of the prevention of Rh immunisation].
    Pinon F; Cregut R; Poulain M; Huchet J
    Gynecol Obstet (Paris); 1969; 68(5):469-78. PubMed ID: 4189000
    [No Abstract]   [Full Text] [Related]  

  • 37. [The problem of antibody control during the first days after anti-D prophylaxis].
    Ennker J; Maas DH; Schneider J
    Fortschr Med; 1978 Sep; 96(33):1650-6. PubMed ID: 100401
    [No Abstract]   [Full Text] [Related]  

  • 38. [Our diagnostic and therapeutic experience in the treatment of Rh-incompatible pregnancy].
    Damilano C; Bruno GL; Brignone S
    Minerva Med; 1973 Oct; 64(70):3683-8. PubMed ID: 4767750
    [No Abstract]   [Full Text] [Related]  

  • 39. Reproductive immunology.
    Scott JR; Beer AE
    Obstet Gynecol Annu; 1974; 3(0):101-36. PubMed ID: 4138671
    [No Abstract]   [Full Text] [Related]  

  • 40. Immuno-prevention of Rh hemolytic disease of the newborn.
    McConnell RB; Woodrow JC
    Annu Rev Med; 1974; 25():165-78. PubMed ID: 4132885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.